Organto Foods (OGO) Q4 2024 earnings summary

Executive summary

• Fiscal 2024 marked a significant restructuring and realignment, including streamlining the product portfolio, refocusing go-to-market strategies, and reducing costs through internal reorganization and the sale of three subsidiaries.

• Business performance accelerated in the second half of 2024, with strong sales and gross margin growth on a streamlined cost base.

• The company completed a private placement, settled shares for debt, and expects conversion of outstanding convertible debentures to equity, positioning for future growth.

Financial highlights

• Fiscal 2024 sales reached $20.7 million, up 48% year-over-year from $14.0 million.

• Gross profit was $1.8 million (8.5% of sales), up 35% from $1.3 million (9.3% of sales) in the prior year.

• Adjusted gross profit was $1.8 million (8.6%), compared to 8.4% in the prior year.

• Cash operating expenses were $3.3 million (15.8% of sales), up from $2.3 million (16.6% of sales) year-over-year.

• Net loss from continuing operations was $3.3 million, improved from a $5.6 million loss in the prior year; net loss including discontinued operations was $2.0 million, compared to $13.4 million in 2023.

Outlook and guidance

• Management expects continued positive momentum into 2025, focusing on achieving positive cash flow and leveraging recent financing and restructuring.

• The company remains committed to building a world-class foods business serving healthy foods markets and creating long-term value.